2025 HCPCS Code C9800
Dermal injection procedure(s) for facial lipodystrophy syndrome (lds) and provision of radiesse or sculptra dermal filler, including all items and supplies
TAGS: injection radiesse dermal provision sculptra supplies facial lipodystrophy syndrome itemsNotice | HCPCS C9800 terminated on December 31, 2016. |
Short Description | Dermal filler inj px/suppl |
Product Note | 0093 |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Coverage Code | D - Special coverage instructions apply |
HCPCS Code Added Date | July 01, 2010 |
HCPCS Action Effective Date | January 01, 2017 |
HCPCS Pricing Indicator Code | 53 - Statute |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Anesthesia Base Unit Quantity | 0 |
HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C9053 - Inj, crizanlizumab-tmca
- C9054 - Injection, lefamulin
- C9055 - Inj, brexanolone
- C9056 - Injection, givosiran
- C9057 - Inj cetirizine hydrochloride
- C9058 - Injection,pegfilgrastim-bmez
- C9059 - Injection, meloxicam
- C9060 - Fluoroestradiol f18
- C9061 - Injection, teprotumumab-trbw
- C9062 - Daratumumab hyaluronidase
- C9063 - Injection, eptinezumab-jjmr
- C9064 - Mitomycin pyelocalyceal inst
- C9065 - Romidepsin non-lyophilized
- C9066 - Sacituzumab govitecan-hziy
- C9067 - Gallium ga-68 dotatoc
- C9068 - Copper cu-64, dotatate, dx
- C9069 - Belantamab mafodontin-blmf
- C9070 - Injection, tafasitamab-cxix
- C9071 - Injection, viltolarsen
- C9072 - Inj, imm glob asceniv